global medical manufacturer since 1973 celebrating 50 years

Reduces 30-day Mortality*
Helping to resolve the ‘blind spot’ of
Transesophageal Echocardiograms (TEE).
A-View® Endotracheal Balloon Catheter is used to overcome the limitation of the so called ‘blind spot’ of TEE. After introduction of the saline filled catheter in the trachea, echo conduction through the trachea is enabled and the ascending aorta, aortic arch and its branching vessels can be imaged. For more information about A-View see the guide below. 

* Impact of Modified Transesophageal Echocardiography on Mortality and Stroke after Cardiac Surgery:
  A Large Cohort Study. (See TRIFOLD for details from the study.)

Brain Red with Blue
Stroke remains one of the most devastating complications of cardiac surgery.

“Epidemiology of stroke after cardiac surgery in the current era” (p. 1121),
The Journal of Thoracic and Cardiovascular Surgery (Volume 134, Number 5).

Allows Real-time Adjustment
A-View® Device Indications:
  • Detection of Atherosclerosis
  • Diagnosis of Aortic Diseases
  • Monitoring Vascular and Cannula Flow
Contraindications:
May not be used in case of severe respiratory failure, tracheomalacia or contraindications for the use of TEE (e.g. systemic tissue disease affecting the esophagus and/or trachea tissue to a degree not compatible with any aspect of TEE).
A-View-5-lighter
30% Reduction in Mortality*
  • Open Heart Procedures
  • Transcatheter Heart Interventions
  • Aortic Stenting
  • Robotic Cardiac Surgery
  • Aortic Dissection Diagnosis

* Impact of Modified Transesophageal Echocardiography on Mortality  
  and Stroke after Cardiac Surgery: A Large Cohort Study.
  (See TRIFOLD for details from the study.)

brain-scans

* A-View is a registered trademark of Stroke2Prevent BV. The DeRoyal logo and Improving Care.
  Improving Business. are registered trademarks of DeRoyal Industries, Inc.

request more info:
Register for Webinar(s):